Sida i infecció per VIH
Publicacions destacades
-
Efficacy of Elbasvir/Grazoprevir in Early Chronic G1/G4 Hepatitis C infection in HIV/HCV co-infected patients with mild fibrosis
Laguno Centeno M; Alvarez B; Martínez-Rebollar M; de la Mora L; Prieto L;(...)González-Cordón A; Torres B; Cabello A; Gorgolas M; Mallolas J .Referència:Gastroenterologia Y Hepatologia 2021.
-
Primary HIV-1 infection in users of pre-exposure prophylaxis
Ambrosioni J; Petit E; Liegeon G; Laguno M; Miró JM ;Referència:Lancet Hiv 2021.
-
Immunological and virological efficacy of different antiretroviral regimens initiated during acute/recent HIV infection
Ambrosioni J; Farrera J; de Lazzari E; Nicolás D; Manzardo C;(...)Sánchez-Palomino S; Fernández E; Plana M; Miró JM; Hospital Clinic Acute/Recent HIV Study Group.Referència:Aids 2020.
-
Clinical characteristics, risk factors, and incidence of symptomatic COVID-19 in adults living with HIV: a single-center, prospective observational study
Inciarte A; Gonzalez-Cordon A; Rojas J; Torres B; de Lazzari E;(...)Ambrosioni J; Miro JM; Martinez E; Blanco JL; (on behalf the COVID-19 in HIV Investigators).Referència:Aids 2020.
-
Recommendations for measuring HIV reservoir size in cure-directed clinical trials
Abdel-Mohsen M; Richman D; Siliciano RF; Nussenzweig MC; Howell BJ;(...)Frank I; Riley JL; Tebas P; Montaner LJ; BEAT-HIV Delaney Collaboratory to Cure HIV-1 infection.Referència:Nature Medicine 2020.
-
COVID-19 in patients with HIV: clinical case series
Blanco JL; Ambrosioni J; Garcia F; Martínez E; Soriano A;Mallolas J; Miro JM.Referència:Lancet Hiv 2020.
-
A 24-week pilot study of dual maintenance therapy with raltegravir and lamivudine
de Lazzari E; Lonca M; Rojas J; Gonzalez-Cordon A; Blanch J;(...)Mallolas J; Sanchez-Palomino S; Plana M; Blanco JL; Martinez E .Referència:Aids 2019.
-
Time to change cardiovascular prevention in people with HIV
Martinez E;Referència:Lancet Hiv 2019.